Literature DB >> 11594764

Identification of Nash1, a novel protein containing a nuclear localization signal, a sterile alpha motif, and an SH3 domain preferentially expressed in mast cells.

T Uchida1, A Nakao, N Nakano, A Kuramasu, H Saito, K Okumura, C Ra, H Ogawa.   

Abstract

By using a serial analysis of gene expression (SAGE), we have identified a novel full-length cDNA that is preferentially expressed in human cord blood-derived mast cells. The predicted protein showed unique primary structure with a nuclear localization signal (NLS), a sterile alpha motif (SAM), and a Src homology 3 domain (SH3) (termed Nash1). Nash1 was mapped to human chromosome 21q11.1 and highly expressed in spleen, liver, peripheral blood, and mast cell lines. In consistent with the presence of NLS, Nash1 was localized in the nucleus. Interestingly, screening gene databases for Nash1-related sequences revealed the existence of a Nash1-related gene termed SLY that was preferentially detected in lymphoid cells. We also found at least two additional candidates for this gene family in the database. These findings suggested that Nash1 and Nash1-related proteins consisted of a novel family of signaling/adaptor proteins, and Nash1 might function as a signaling component of mast cells, possibly in the nucleus. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594764     DOI: 10.1006/bbrc.2001.5722

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.

Authors:  Lisa J Martin; James P Franciosi; Margaret H Collins; J Pablo Abonia; James J Lee; Kevin A Hommel; James W Varni; J Tommie Grotjan; Michael Eby; Hua He; Keith Marsolo; Philip E Putnam; Jose M Garza; Ajay Kaul; Ting Wen; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2015-06       Impact factor: 10.793

2.  Impaired immune responses and prolonged allograft survival in Sly1 mutant mice.

Authors:  Sandra Beer; Tanja Scheikl; Bernhard Reis; Norbert Hüser; Klaus Pfeffer; Bernhard Holzmann
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

3.  Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer.

Authors:  C Rimkus; M Martini; J Friederichs; R Rosenberg; D Doll; J R Siewert; B Holzmann; K P Janssen
Journal:  Br J Cancer       Date:  2006-10-31       Impact factor: 7.640

4.  The orphan adapter protein SLY1 as a novel anti-apoptotic protein required for thymocyte development.

Authors:  Bernhard Reis; Klaus Pfeffer; Sandra Beer-Hammer
Journal:  BMC Immunol       Date:  2009-07-15       Impact factor: 3.615

5.  SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.

Authors:  Yong Yan; Lei Zhang; Tao Xu; Jinxu Zhou; Rong Qin; Chao Chen; Yongxiang Zou; Da Fu; Guohan Hu; Juxiang Chen; Yicheng Lu
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

6.  Characterization of the role of Samsn1 loss in multiple myeloma development.

Authors:  Natasha L Friend; Duncan R Hewett; Vasilios Panagopoulos; Jacqueline E Noll; Kate Vandyke; Krzysztof M Mrozik; Stephen Fitter; Andrew C W Zannettino
Journal:  FASEB Bioadv       Date:  2020-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.